2025 VBEF Resource Pack Teaser: 300+ Industry Leaders, 2000+ Enterprise Connections, and 20+ Forum Agendas Unveiled!
China’s Medical Innovation Assets Experience a Surge, Driving the “Healthy China” Initiative into a Period of Value Reassessment: The Launch of 48 Domestically Developed Class 1 New Drugs Hits a Historical Peak, While Breakthroughs in Both Scale and Quality of License-out Transactions Underscore the Global Competitiveness of Chinese Pharmaceutical Companies; In the Medical Device Sector, 66 Innovative Products Gain Approval, with a 56% Rate of Original Innovation Highlighting Prowess in Technological Breakthroughs.
However, beneath the surge, the challenges of translation have become prominent:
Innovative enterprises possess core hard-tech assets yet struggle to find ideal partners, while the value proposition of innovative products risks being overlooked due to limited visibility.
Investment institutions lack systematic asset discovery mechanisms and precise valuation frameworks, facing the dilemma of "holding capital but struggling to find hidden gems";
“Demand-Supply Mismatch” Across the Upstream and Downstream of the Industry Chain: The Industrial Sector Urgently Needs to Break the Dual Shackles of Information Silos and Resource Misallocation.
To bridge the information gap and address resource misalignment between supply and demand, VCBeat has prioritized “innovative asset trading” as a key theme. The 2025 Top 100 Future Healthcare & Pharma Exhibition (hereinafter referred to as VBEF) was held in Suzhou on May 9–10, featuring five major segments: forums, awards, exhibitions, reports, and resource matchmaking. This initiative continues to create business development opportunities for innovative assets, providing an optimal platform for industry stakeholders to meet their comprehensive, multi-level needs—including efficient investment and financing, BD collaborations, industrial and supply chain transactions, finished product trading, and overseas market expansion.
For Premium Assets and Buyers, Choose VCBeat VBEF First
Assist sellers of innovative assets in showcasing their technological capabilities and connecting with industrial resources.
Value Assessment Builds Buyer Trust Endorsement:2025 Future Healthcare Top 100: Authoritative Selection Certifies the Quality of Innovation;
Product Interpretation Enhances Asset Bargaining Power:Product Launches and Expert Interpretation of Industry Reports to Showcase the Innovative Value of Assets;
Immersive Scenario Display in the 10,000-square-meter Exhibition Area:A 15,000-square-meter Innovation Exhibition Area features a dedicated Innovation Asset Poster Corridor to address the industry’s longstanding challenge of “good products going unnoticed due to poor visibility.”
Precisely reach 2,000+ investor buyers:Top 100 Most Active Investment Institutions in the Past Three Years, 200+ Direct Investment Funds from 20+ Key Cities, 300+ Venture Capital Firms Across 30 Prime Sectors, and 50+ Industry Leaders × 100+ Corporate Investors × Sovereign Wealth Funds from 10 Countries—All Present for Product Selection.
Assist buyers in seeking high-quality assets, identify future unicorns, and select superior assets.
Directly liaise with the asset decision-making level:Independent Asset Matchmaking Zone + Premium Project Promotion Conference: “Come with Needs, Leave with Partnerships”
Get first-hand insights from 300+ industry leaders:2 Main Forums and 4 Featured Forums analyze frontier technologies and market trends, while 20+ Thematic Forums discuss hot topics to uncover new opportunities in the future of healthcare.
On-site Selection of 1,000+ High-Quality Assets:15,000 sqm exhibition space, 150+ exhibitors, and 1,000+ innovative assets covering early-stage, growth-stage, and publicly listed companies. Concurrently, N+ networking activities—including matchmaking sessions, closed-door meetings, and project roadshows—will be held to precisely match needs for investment, collaboration, and resource alignment.
VBEF has gradually established“Find Innovative Assets, Seek Quality Buyers—Choose VCBeat VBEF”brand label, propelling the revaluation of China’s medical innovation assets into a new era of efficient allocation.
Limited-Time Early Bird Tickets: Hot Sale in Progress!
As low as¥69!(Deadline: March 31)
Free tickets available—limited quantity, first come, first served!
Share this article to your WeChat Moments and collect 18 likes,
Add the Organizing Committee (Note: Ticket Benefits),
Receive one early-bird ticket (meal not included) for free!
Deadline: March 31, 2025.
Ms. Jing - Conference Registration Inquiry
Mr. Weng - Conference Registration Inquiry
(Proposed schedule; specific forums and session times are subject to on-site arrangements)
May 9, 09:00-17:00
★Forum News
● Gao Guobiao |The Party Secretary and Deputy Director of the Center for Medical Device Evaluation, formerly under the China Food and Drug Administration, has confirmed attendance;
● Zhao Guoping | Academician of the Chinese Academy of SciencesConfirmed attendance;
● Xu Shuqiang | Former Director of the Department of System Reform, National Health Commission; Chair Professor, Shanghai Jiao Tong University; Dean, China Hospital Development Research Institute, confirmed to attend;
● Yuan Xin, Director of the Center for Aging Development Strategy Research at Nankai University and Vice President of the China Population Association, has confirmed his attendance;
● Scott Boyd | Deputy Director, Strategy & Implementation Management, China Office, Gates Foundation confirmed to attend;
● Cai Daqing | Founding Partner of Sherpa Capital confirms attendance;
● Li Li | President of Aier Eye Hospital Confirmed to Attend;
● Tu Zhiliang, Chairman of Gushengtang, Confirmed to Attend;
● Shen Dinggang, CEO of United Imaging Intelligence, confirms attendance;
● Zhang Ling | Senior Technical Expert at the DAMO Academy Medical AI Laboratory and Head of Multi-Cancer Screening Technology, confirmed to attend;
● Li Datao, Founder of VCBeat, Confirmed to Attend;
Trend Tipping Point: Interpreting Shifts in Macro Waves
▸ Opening Ceremony Address
▸Technology Outlook: The Technological Possibilities of Life Sciences from Geography to Space
▸The Tipping Point of Systemic Reshaping: Insights into Opportunities for Structural Change in the Healthcare System
▸The Tipping Point in Payment Reform: Cost Containment in Health Insurance and the Evolution of Healthcare Payment Systems
▸Demographic Shifts: Changes in Industry Demand Amid an Aging Population
▸Unlocking the Global Potential of Healthcare Innovation: Reshaping Health Equity Through Technology and Collaboration
▸Expert Dialogue: The Tipping Point of the Private Healthcare System and Market Development Amidst New Industrial Transformation
Tipping Point of Trends: Interpreting the Direction of Industrial Innovation
▸ Development Opportunities in the Integration of Medicine and Engineering: Innovation in Translational Practice
▸ Dialogue with Industry Leaders: Envisioning an Ecosystem for Original Innovation
▸ Intelligent Healthcare: Innovative Applications of Large AI Models in the Medical Field
▸ Core Technological Innovation: Driving Global Expansion and Win-Win Collaboration
▸ Breaking the Monopoly: The Path to Domestic Production of High-End Medical Devices
▸ The Rise of Domestically Produced Medical Devices: A Leap from Substitution to Innovation
▸ Expert Dialogue: Innovation Opportunities and Challenges in the Medical Device Supply Chain
May 10, 09:00-17:00
★Forum News
● Zhang Yuhui, Member of the Party Committee and Deputy Director of the Hainan Provincial Health Commission, and President of the Global Branch of the Health Economics Society, has confirmed his attendance;
● Yu Zeren | Senior Director, Life Sciences Real Estate, JLL, confirmed to attend;
● Lu Gang | Partner at Legend Star Confirmed to Attend;
● Ding Zhaoliang (Danggui) | Founder and CEO of Knowledge Matrix confirms attendance;
● Fei Jianjiang | Managing Partner of Yuanhe Origin Capital Confirmed to Attend;
● Wang Xun | Chief Investment Officer of Huagai Capital confirms attendance;
● Jinghua Wang | Managing Partner, Medtronic China Fund Confirmed to Attend;
● Wang Junfeng, Co-Chief Investment Officer of Legend Capital, Confirmed to Attend;
● Wang Zhixing, President of Wuxi Innovation Investment Group Co., Ltd., confirmed to attend;
● Liu Dan | Managing Partner of Pivotal bioVenture China Confirmed to Attend;
● Cai Zixuan, Director of the International Department of the China Association for Promotion of UN Procurement, has confirmed his attendance;
● Gao Guangyong, Chairman of Shanwaishan, Confirmed to Attend;
● Wang Yingqi, Co-founder & CEO of TopEye Medical, confirmed to attend;
● Shen Sheng | Director, Investment Banking Division, Haitong Securities confirms attendance;
● Zhao Dongyue, Co-founder and Vice President of Huangfeng Capital, confirmed to attend;
● Liu Tingting | Partner at AllBright Law Offices confirms attendance;
● Guotai Junan,Ping An Health,China Association of Medical EquipmentConfirmed attendance at the forum;
Excellent Solutions at the Tipping Point: A New Corporate Strategy
▸ Internet Healthcare: Content Marketing Opens a New Chapter for the Industry
▸ Decoding Spatial Innovation in the Healthcare Industry: Efficiency Leaps Driven by Scientific Site Selection and Industrial Park Agglomeration, with International Benchmarking
▸ How Medical Intelligence Is Reshaping the Future Healthcare Ecosystem
▸ Digital Investment Strategy: From Cost Reduction and Efficiency Enhancement to Value Creation
▸ Digital Intelligence Empowerment, Content Value Enhancement: Innovative Strategies for the “People-Product-Place” Ecosystem in the Greater Health Industry
▸ Strategic Transformation and Industrial Ecosystem Reshaping Amid the M&A Wave
▸ Expert Dialogue: Investment Opportunities for Healthy China Development Under the New Landscape
Development Opportunities at the Tipping Point: Global Layout
▸ Cross-Border Medical Collaboration and Innovative Models: China’s Experience and New Pathways for Global Health Governance
▸ Prospects for the Internationalization Development Model and Path of China’s Medical Device Industry
▸ Pathways and Strategies for Chinese Enterprises Going Global—UN Procurement
▸ The EU MDR Regulatory Storm: How Can Chinese Medical Device Companies Cross the Life-and-Death Line of Compliance?
▸ From Domestic to Global: Overseas Expansion and Development Practices of Blood Purification Equipment
▸ After Achieving Technological Breakthroughs, Chinese-Made High-End Imaging Equipment Goes Global and Reaps Lucrative Profits
▸ Breaking Through to Build a New Ecosystem for Cross-Border Financial Services
▸ Expert Dialogue: Practices, Opportunities, and Challenges in Cross-Border Business Development for Medical Devices
Co-hosted by: Enshe Capital
May 9, 09:00-17:00
★ Forum News
● EnsCapital, as a co-organizer, jointly hosted this forum;
● Ren Haiping, Minister of the Industrial and Scientific Research Development Department at Sinopharm Medical Device, has confirmed attendance;
● Song Qi, Secretary of the Party Committee of Neusoft Medical, confirmed attendance;
● Fu Shinong, CEO of Sinovision, confirmed to attend;
● Jingyuan Li | Chief Technology Officer of MathWorks China Confirmed to Attend;
● Xinsheng Jiechuang, Wuxi Hongxin Sensing, Wuxi Yisheng Micro-Nano, and Zhishu Technology have confirmed their attendance at the forum;
Breakthroughs in Core Components of Chinese CT Scanners from the Perspective of Global Trends in Medical Imaging Innovation
▸ Collaborative Innovation and Future Trends in the Medical Device Industry
▸ Data-Intelligence Driven, Reconstructing a New Ecosystem for Smart Imaging in Healthcare
▸ Moving Up the Global Value Chain: A Value Leap from Specialized Innovation to Global Intelligent Manufacturing
▸CT Detector Technology Ushers in a New Era of High-Resolution Imaging
▸Breakthroughs and Innovations in CT X-ray Tube Technology
▸ Foundational Perspectives on Investment Logic in Medical Device Design and Manufacturing
▸ Roundtable Discussion: Independent R&D and Manufacturing of Medical Devices Amid New Opportunities
Leading Chinese Medical Imaging Manufacturers Drive Supply Chain Innovation: Continuous Innovation and Upgrading of Core Components
▸ The Path to Original Innovation Driven by New Quality Productive Forces
▸ Innovative Technologies Empower the Development of Medical Imaging
▸ Innovative Sensing Technology Drives the Upgrade of Medical Devices
▸ The Path to Domestic Production of High-End Ultrasound Transducers
▸ Independent R&D and Manufacturing of Medical Devices Amid New Opportunities
Value Creation by Third-Party Players in the Medical Device Design and Manufacturing Industry Chain
▸ From Incubation to Investment: Leveraging Upstream Innovation in the Medical Device Industry at Its Source
▸ Boosting the Innovative Development of China’s Domestic Medical Imaging Industry
▸ Tackling the “chokepoint” challenges in medical imaging equipment from the source
May 10, 09:00–12:00
★ Forum News
● Chen Tao, Chairman of Dongmai Medical Group, has confirmed his attendance;
● Jingyuan Li | Chief Technology Officer of MathWorks China confirmed to attend;
The Emergence of Source Innovation in the Context of Medical-Engineering Integration
▸ R&D Innovation: The Path to Translating Medical-Engineering Innovations into Practice
▸ Key Elements and Pathways for Source Innovation in Medical Devices
▸ CDMO Empowers the Integration of Medicine and Engineering
▸ Regulatory Trends in the High-Quality Development of China’s Medical Device Oversight
▸ Bridging the Innovation and Translation Chain to Build a New Ecosystem for Medical-Engineering Translation
▸ Ceremony Segment
▸ Roundtable Discussion: Synergistic Challenges and Opportunities in Early-Stage Design and Clinical Development, as well as Source Innovation and Manufacturing
May 9, 09:00-17:00
★ Forum Flash News
● Academician Ma Dawei of the Chinese Academy of Sciences has confirmed his attendance;
● Song Weiping, President of Dabeinong, Confirmed to Attend;
● Dr. Chen Zeping, Founder & CEO of Shanghai Yanyin Technology Co., Ltd., confirmed to attend;
● Gao Qi, Director of Bose Quantum Algorithms, has confirmed attendance;
● Lide Health confirms attendance at the forum;
Release of Global Industry Innovation Trends
▸ Opening Remarks
▸ Analysis of the Global Innovation Ranking in the Biomanufacturing Industry
▸ Launch Ceremony of the Global Biomanufacturing Industry Innovation Consortium
▸ Signing Ceremony for Key Project Collaborations
▸ Decoding the New Era of Convergent Development in Life Sciences
▸ Biomanufacturing and New Quality Productive Forces
▸ Synthetic Biology Engineering of Microbial Resources
▸ Discovery of Intracellular Metabolic Pathways and Industrialization of Synthetic Biology
▸ Applications of Industrial Biotechnology in the Biofuel and Chemicals Sectors
Golden Investment Opportunities and Trend Outlook in Global Biomanufacturing
▸ Reflections on the Global Expansion of Chinese Biomanufacturing Companies
▸ Leveraging CVC as the Engine to Expand New Growth Curves for Industry Leaders
▸ Discussion on VC/PE Investment Strategies and Key Transaction Points in Biomanufacturing
▸ Investment Opportunities in Key Equipment for Biomanufacturing
▸ AI and Digitalization Empower Innovation in Biopharmaceutical R&D
▸ Light-Speed Screening of Trillions of Molecules—Quantum Computing Ushers in a New Era of Drug Discovery
▸AI-Driven Innovation and Transformation in the Biomanufacturing Industry
▸ Roundtable Discussion: Where Are the Golden Opportunities in Biomanufacturing from the Perspective of State-Owned Capital and Guidance Funds?
▸ Roundtable Discussion: Where Are the Golden Opportunities in Biomanufacturing from the Perspective of Industrial Capital?
May 10, 09:00–17:00
Biomanufacturing: The Beautiful “She” Power
▸“1 Acid + 2 Factors”: How to Capture Half of the Cosmetic Ingredients Market
▸Recombinant Collagen: A 20-Year Recombinant Anti-Aging Formula
▸Persisting in Innovation and Creation: Huaheng’s Exploration of Biomanufacturing
▸Analysis of the “She” Economy in Biomanufacturing
▸The Rise of Domestic Biomanufacturing in China
▸Natural Cyclic Peptides and Plant Biomimetic Technology: A New Blue Ocean for Anti-Aging Ingredients
▸Roundtable Discussion: Biomanufacturing Beauty’s “Her” Power
▸Award Ceremony: Presentation of the Bio-Manufacturing “Fangxin Award” (Cosmetics and Medical Aesthetics Categories)
▸ Award Ceremony: Presentation of the "Qiufen Prize" for Biomanufacturing (Pharmaceuticals, Healthcare, and Health Technology)
▸ Award Ceremony: Presentation of the Biomanufacturing “Chunhui Award” (Female Professionals)
“Where Is the Next Hyaluronic Acid?” Launch of High-Potential Projects and Blockbuster Products
▸ Achieving the Chemically Impossible: How to Trigger the Tipping Point for HMOs
▸ Chlamydomonas Synthetic Biology Disruptive Innovation Platform: A Green Revolution from the Lab to Beauty Products
▸ Discovery of Meta-Protein: The Future of Third-Pole Food Is Here
▸ A Collagen Alternative: The Next Generation of Anti-Aging Makes Its Debut
▸ Biomanufacturing Empowers Animal Nutrition
▸ The Future of Bio-based Materials
▸ Biochips and High-End Active Pharmaceutical Ingredients
▸ Enzyme Engineering and Strain Design
▸ Novel Foods and Nutrients
Co-organized by: Guoke Hengtai
May 9, 09:00-12:00
★Forum Flash News
● Guoke Hengtai, as a co-organizer, jointly hosted this forum;
● Cao Jinci, General Manager of the Marketing Shared Service Platform for Distribution Channels at Guoke Hengtai Ai, has confirmed his attendance;
● Wang Zewei, Head of Strategic Cooperation and Investment Department at Guoke Hengtai, has confirmed his attendance;
● Liu Shaohua, Marketing Manager at Guoke Hengxing, has confirmed his attendance;
● Liu Tianyi, Head of the CDMO Shared Manufacturing Department at Guoke Hengtai, confirmed to attend;
● Chao Daidi, Head of the Logistics Planning Department at Guoke Hengtai, has confirmed her attendance;
Factory Tour
Innovative Model
Empowering Distributors, Winning Together in the New Era
Smart Leaders
Product Launch
Empowering the Future
▸ Empowering Innovative Medical Devices, Co-Creating and Co-Investing Together
▸ Digitalization Promotes High-Quality Compliance Development Under New Circulation Regulations
▸ End-to-End CDMO + Shared Service Platform Boosts Efficiency and Accelerates Growth in the Medical Device Industry Chain
▸ Sinopharm Hengtai Shared Logistics Services: Sinopharm Hengtai Third-Party Logistics, Empowering Business Growth
Expert Insights
VCBeat Innovative Product Roadshow
May 10, 09:00–17:00
★ Forum Flash News
● Sun Yuewu | Chairman of the Committee, China Association for the Promotion of Pharmaceutical and Health Development, Confirmed to Attend;
● Wang Rui | Secretary-General of the Health Growth Society confirms attendance;
● Prof. Duan Tao | Shanghai First Maternity and Infant Hospital confirms attendance;
● Yin Yuehan, Executive Director at Hengxu Capital, confirmed to attend;
● Li Jing, Founder and CEO of Fanzhuo Group, confirmed to attend;
● Wu Yinsong, Founder and Chairman of Xiushi Biopharmaceuticals (Nantong) Co., Ltd., confirmed to attend;
● Bao Xiufei, Chairman of Guangzhou Baiyunshan Huang Da Health Products Co., Ltd., has confirmed his attendance;
● Tan Weifeng, Vice President of Sichuan Zhenghexiang Group and General Manager of the Innovation Business Center, has confirmed his attendance;
● Dong Qing, Vice President of the Drug Marketing Department at Hua Medicine, confirmed to attend;
New Products
▸ Interpretation of the Latest Policies on the Out-of-Hospital Market and Analysis of Product Opportunities
▸ Final-Game Speculation on the Trillion-Yuan Out-of-Hospital Market for Pharmaceutical Companies: From Traffic Wars to Ecosystem Positioning
▸ To All Long-Termists: The “Spark Paradigm” for Sustainable Growth in Healthcare
▸ Harnessing the Power of Content to Build High-Impact Healthcare Traffic IPs
▸ E-commerce Driven: How to Achieve N-fold Growth for Pharmaceutical and Medical Device Brands and Operations
▸ Investment Strategies and Business Growth Logic for Foods for Special Medical Purposes (FSMP)
▸ Breaking Through E-Commerce Growth Barriers: Deep Integration of Data, Technology, and User Experience
▸ Roundtable Discussion: Decoding the Breakthrough Path for Chinese Medical Aesthetic Materials: Frontier Technologies, Industrial Synergy, and New Consumer Channels
New Business
▸ Blockbuster Formula: The Omnichannel Growth Code for Healthcare Products
▸ From Private Domains to “Mindshare Domains”: Awakening the Lifetime Value of Healthcare Users
▸ Roundtable Discussion: When New Products Meet New Channels: Reconstructing the User Reach Formula for Blockbuster Products with Sales Exceeding RMB 1 Billion
▸ From “Trust” to “Confidence”: The Baseline and Upper Limit of Content-Driven Marketing in Healthcare
▸ Old Bottles, New Wine: DTP Pharmacies Become a Key Channel for the Launch and Promotion of Innovative Drugs
▸ The Explosion Law of Home Medical Devices: Traffic Wave-Making Techniques in E-commerce Marketing
▸ Industrial Upgrading Amid Consumption Downgrading: Potential and Opportunities in the Healthy Food Industry
▸ Roundtable Discussion: The Journey to “C”: Exploring Out-of-Hospital Market Opportunities and Practical Strategies for Multi-Category Products
May 9, 09:00-12:00
★ Forum Flash News
● Deng Bin | Co-founder of Taozi HealthConfirm Attendance;
● Zong Wenhong, CEO of Xikang Cloud Hospital, confirms attendance;
● Qu Yi, Chairman and CEO of Nateri, confirmed to attend;
Construction Effectiveness
▸ Innovation and Challenges Behind the Development of Internet Hospitals
▸ Achievements and Reflections on the Construction of Smart Hospitals at National Regional Medical Centers
Innovative Exploration
▸ Smart Healthcare Practices on Internet Medical Platforms
▸ Reflections and Explorations on Digital Healthcare Internet Product Platforms
▸ Innovative Development and Operational Practices of Internet Nursing Platforms
▸ Practices and Explorations in Building a Big Data Management and Control Platform for Scientific Research
Opportunities and Challenges
▸ Roundtable Discussion: Opportunities and Challenges in the Development of Internet Hospitals and Smart Hospitals
May 9, 09:00–12:00
★ Forum News Flash
● Zhao Yu (Mai Dong) | Vice President of Knowledge Matrix and Head of the Medical Business DivisionConfirm attendance;
● Jiankang Zhilu and Huimei Digital Technology have confirmed their attendance at the forum;
Grasping Pharmaceutical Marketing Trends
▸ Practical Applications and Development Trends of Digitalization in Pharmaceutical Marketing
Innovative Exploration by Pharmaceutical Companies
▸New Retail Strategy for Pharmaceuticals
▸How AI Becomes a Strategic Force in Pharmaceutical R&D and Marketing
Platform Empowers Precision Marketing
▸ Omnichannel Pharmaceutical Marketing to the General Population in the Digital Age
▸ The Dual Flywheel Effect Drives Value Realization for All Stakeholders
▸ Provision of Digital and Intelligent Tools Amid the Wave of Digital Transformation in Pharmaceutical Companies
New Trends in Digital Marketing
▸ Roundtable Discussion: New Trends in Digital Marketing
May 9, 09:00–12:00
★Forum News
● Shen Li | Secretary-General of the China Cardiovascular Doctors Innovation Club (CCI) and Chief Physician of the Department of Cardiology at Zhongshan Hospital, Fudan University, has confirmed his attendance;
● Gu Leimin, Partner at YuanSheng Venture Capital, Confirmed to Attend;
● Peng Huiqun, Founder and CEO of Puchuang Medical, confirmed to attend;
● Li Yingjun, General Manager of Tonghe Litai, confirmed to attend;
● Proxima Ventures confirms attendance at the forum;
Keynote Address
▸ Breaking Boundaries · Integration · Win-Win: Exploring the Clinical-Driven Model of Cardiovascular Innovation
▸ How Cardiovascular Device Companies Can Crack the Commercialization Challenge
▸ Release of the “Research Report on Ablation Technologies and Market Trends”
▸ Major Players Increase Investment, Domestic Innovation Surges: PFA Set to Dominate Cardiac Ablation Technology in the Next Decade
▸ Technological Innovation: Making Healthcare More Precise and Efficient
▸How CROs Empower the Rapid Approval of Domestically Developed Innovative Cardiovascular Devices
Roundtable Discussion
▸ The Path of Transformation, Opportunities, and Challenges for Cardiovascular Devices
Co-organized by: ATLATL Innovation Center
May 9, 14:00–17:00
★ Forum News Flash
● ATLATL Dart Innovation Center, as a co-organizer, jointly hosted this forum;
● Zhu Pengcheng, Founder of ATLATL Innovation R&D Center, Confirmed to Attend;
● Zhou Lu | Founder of Shentuo Bio confirms attendance;
Clinical Perspective
▸ AI-Empowered Drug R&D: The Path from Laboratory to Clinical Translation
▸ Regulatory Science Development in AI-Driven Drug Discovery
Industry Empowerment
▸ Digital Transformation and Asset-Light Models in Biopharmaceutical R&D / Cross-Border Collaborative Innovation in Biotechnology and Information Technology
▸ Capital Opportunities and Challenges in AI-Driven Drug Discovery: Investment Strategies and Future Trends
Industrial Chain Perspective
▸ AI-Empowered Proteomics Research: From Structure Prediction to Functional Exploration
▸ AI-Driven Drug Discovery and Design
▸ Roundtable Discussion: The Tool Revolution—Technological Innovation, Regulatory Challenges, and Industry Ecosystem Building
Co-organized by: He Eye Hospital
May 9, 14:00-17:00
★ Forum News
● He Eye Hospital, as a co-organizer, jointly created this forum;
● He Eye Hospital and Zhaohua Health Fund have confirmed their attendance at the forum;
Innovative Development of AI in Ophthalmology
▸ Partnering with Artificial Intelligence to Comprehensively Build an Eye Health Ecosystem Management System
▸ Assessment of Investment Trends in the Ophthalmology Industry
▸ Report Release: "Research Report on the Localization Process of High-End Ophthalmic Equipment"
▸ The Rise of the "Hundred-Endoscope War": Four Major Ophthalmology Segments Take Off Strongly
▸ Amid the "Hundred Models War," Five Major Opportunities for Ophthalmic Gene Therapy
▸ Roundtable Discussion: Opportunities and Challenges in Ophthalmology Amid the New Wave of Artificial Intelligence
Innovative Development of High-End Ophthalmic Devices
▸ Leveraging Early Diagnosis of Glaucoma to Drive Innovation and Development of Domestically Produced Ophthalmic Devices
▸ Breaking the Import Monopoly: Chinese Companies Enter the SMILE Laser Surgery Market
▸ Roundtable Discussion: Domestic Substitution and Innovation in High-End Medical Devices?
Co-hosted by: Probe Capital
May 9, 13:30–17:00
★ Forum News Flash
● Probe Capital co-organized this forum as a joint host;
● Zhao Du | Head of Shangtang Medical’s Strategic Investment Department Confirmed to Attend;
● Wang Jian, Founder of Jianhai Technology, Confirmed to Attend;
● Xue Chong | Founder and CEO of Quanzhen Medicine confirmed to attend;
● Wang Zeyuan, Founder of Lingxi Medical, Confirmed to Attend;
Opening Remarks by the Organizer
▸ Large AI Models Lead a New Paradigm in Healthcare Innovation
Industry Pioneer
▸ Scenario-Driven Empowerment Models and Pathways for Large Language Models in the Medical Vertical
▸ AI Health Coach-Based Post-Consultation Patient Health Service Platform
▸ Building a Large Language Model for Holistic Medicine Amidst the AI Paradigm Shift
▸ Dynamic Evidence-Based Transformation in Medicine Driven by Large Language Models
▸ List Release: Pioneers of Paradigm Shift – Annual List of AI Large Model Medical Innovation Products
Ecological Roundtable
▸ Expert Roundtable: Integrating into Scenarios—Key Elements and Pathways for the Innovative Implementation of Large Medical Models
▸ Expert Roundtable: Pathways to Breakthroughs—Value Validation, Data Ecosystems, and Innovation in Payment Mechanisms
Co-organized by: Probe Capital
May 10, 09:00–12:00
★ Forum Flash News
● Probe Capital co-organized this forum as a joint organizer;
● Ryan Harper | Head of Product Pipeline Strategy and Digital Innovation, Roche Pharma China, confirmed to attend;
● Yu Rong | Chairman of Meinian Onehealth Healthcare Group confirmed to attend;
● Wang Tianze, Head of Digital Strategy at Roche, has confirmed his attendance;
● Xu Bingyu, Founder and CEO of Huamei Haolian, Confirmed to Attend;
● Wang Jun | Co-founder of Weimei Health Confirmed to Attend;
● Xu Qian | Managing Partner of Danlu Capital Confirmed to Attend;
● Bohe Innovation Center confirms attendance at the forum;
Ecological Co-creation Perspective
▸ AI Engine × Big Data: Decoding Meinian’s New Paradigm of AI-Driven Health Management
▸ Exploring the Boundaries of Medical AI Applications, Co-building an Integrated Diagnosis and Treatment Innovation Ecosystem
Application Scenario Perspective
▸ Open-source large language models drive the intelligent upgrade of solutions and products across the entire healthcare industry
▸AI-Empowered Community Hospitals: Enhancing Quality, Reducing Costs, and Improving Efficiency
▸ AI-Empowered Primary Healthcare: Large Language Models Launch a New Paradigm for Smart County-Level Medical Care
▸ Release of the White Paper on "New Quality Productive Forces: Integrated Innovation Practices of Large Models in Healthcare Scenarios"
▸ Generative AI Services Propel Life Sciences Innovation into a New Era
▸ Dialogue with Industry Leaders: The Path to Collaborative Innovation and Development in the AI Industry Amidst New Technologies, Concepts, and Landscapes
May 10, 09:00–12:00
★ Forum News
● Sun Xiaoyu | Vice President of Information Technology, Medtronic Greater China, Confirmed to Attend;
● Wang Rong | Vice President of Eli Lilly China / Head of Eli Lilly China Innovation Collaboration Center confirmed to attend;
● AstraZeneca confirms attendance at the forum;
Benchmark Practices
▸ From Data to Insights: Pfizer’s Digital-Driven Healthcare Innovation
▸ Building Digital Healthcare by Leveraging China’s Ecosystem
▸ Data-Intelligence Driven: AstraZeneca’s Digital Innovation Practices and Ecosystem Building
▸ From Devices to Ecosystem: Industry Transformation Driven by Siemens Healthineers’ Digitalization
▸ Patient-Centered Digital Ecosystem: From Disease Management to Full Lifecycle Services
Ecological Empowerment
▸ Dialogue with Industry Leaders: Opportunities and Challenges in Co-building a Digital Ecosystem
May 10, 09:00–12:00
★Forum Flash News
● Professor Liao Hongen, Tenured Professor at Tsinghua University, Confirmed to Attend;
● Qu Zhi | General Manager of Partel confirms attendance;
● Zhou Guanshan, Director of the Strategic Development Department at Kangji Medical, confirmed to attend;
● Zhang Xiaonong, Founder of Aoruiji Medical, Confirmed to Attend;
● Liu Jianxun, Senior Vice President and General Manager of Product Innovation at Grealis Technology, confirmed to attend;
● Sun Xiaolu | Partner at Proxima Ventures Confirmed to Attend;
● Liu Xiaowei, General Manager of Deneng Medicine, confirmed to attend;
● Zhu Yichen, CEO of Yijiada, Confirmed to Attend;
● Jin Rong | Chief Marketing Officer of Yilu Kuaijian confirmed to attend;
Keynote Address
▸ Intelligent Integration of Minimally Invasive Diagnosis and Treatment: AI-Driven Technological Innovation
▸ Multiple Products Approved! Chinese-Made Electric Endoscopic Staplers Enter a Fast-Track Development Phase
▸ Kangji Medical: The Rise of Chinese-Made Minimally Invasive Surgery (Tentative)
▸ Unlocking the Potential of Novel Biodegradable and Absorbable Metallic Materials in Minimally Invasive Surgery
▸ AI + Surgical Robots: Ushering in a New Era of Minimally Invasive Diagnosis and Treatment
▸ Surviving the Shakeout: How Can Domestic Ultrasonic Scalpel Manufacturers Navigate the “Life-or-Death” Challenge?
▸ New Perspectives on Investment in Minimally Invasive Surgical Instruments: Technological Innovation, Market Trends, and Long-Term Value Creation
Roundtable Discussion
▸ The Path of Transformation, Opportunities, and Challenges in the Minimally Invasive Surgery Industry
Co-organized by: VB New Medicine
May 10, 09:00-17:00
VCBeat Investment Trends and Innovation in Practice
▸ Overview of Full Lifecycle Management for Innovative Drugs and CGT Trends
▸ Global Perspective: Reflections on the Transformation of Underlying Investment Logic in China’s CGT Sector
▸ Panel 1: New Strategies in CGT—Hotspots, Dilemmas, and Breakthroughs
▸ New Technologies Drive the Upgrade of CGT Products
▸ Panel 2: New Strategies in RNA—Hotspots, Dilemmas, and Breakthroughs
▸ Panel 3: Insights on Investment and Financing—Sharing Experiences from Industry Veterans
# Transformation Awakening
▸ Shifting Mindsets and Pathways in Drug Development: From Laboratory to Clinic
▸ Accelerating the Development of the CGT Industry through the Translation and Incubation of Scientific Research Achievements
▸ Empowering Early-Stage Innovation, Realizing Entrepreneurial Dreams
▸ Panel 4: Collaboration on Technology Transfer and Ecosystem Building
VBInsight
▸ Product Perspective – First Look at New BD Opportunities, Then CGT
▸ Panel 5: CGT Global Expansion—Product Export and Supply Chain Internationalization
▸ Panel 6: The Buyer’s Perspective—BD Collaboration Models and Success Stories
May 10, 14:00-17:00
★ Forum News
● Wang Xu, General Manager of the Medical Health Management Department at Sunshine Insurance Group, confirmed attendance;
● Cai Zhuo | Head of ZhongAn Internet Hospital, ZhongAn Insurance, Confirmed to Attend;
● Jing Xing | Founder of Shangyong Technology Confirmed to Attend;
● Wang Bei, Investment Director of Pacific Healthcare Management Co., Ltd., confirmed to attend;
● Mi Jian and Ping An Health have confirmed their attendance at the forum;
Integration and Innovation
▸ How Was the “Wuhou Model” of Integrated Health Management and Health Insurance Formed Through Multi-Pronged Initiatives?
▸ Expanding the Target Population: What Further Exploration Opportunities Exist for Health Insurance Covering Individuals with Pre-existing Conditions?
Health Insurance Innovation
▸ New Trends in the Collaborative Development of Healthcare and Insurance in an Aging Society
▸ Building a Closed-Loop “Insurance + Healthcare” Ecosystem to Pioneer a New Paradigm in Health Management
▸ Focusing on the Frontier: How Is AI Reshaping Health Management and Creating New Opportunities for the Development of Health Insurance?
Health Management Innovation
▸ Data-Driven, Precision Pricing: Reshaping the Health Insurance Value Chain
▸ How can technology empowerment and digital intelligence facilitate the personalized and refined development of health management?
Integrated Innovation
▸ Roundtable Discussion: Innovation and Development Opportunities in Health Management and the Health Insurance Industry
May 10, 14:00–17:00
★ Forum News Flash
● Geng Jia | Deputy Director of the Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University, confirmed attendance;
● Liang Zhikun, Deputy Director of Daan Gene Research Institute, confirmed to attend;
● Yang Min | Senior Program Officer at the Bill & Melinda Gates Foundation confirmed to attend;
● Liu Xiaowei, General Manager of Deneng Medicine, confirmed to attend;
Clinical Perspective
▸ Single-Molecule Biosensing Technology and Innovative Diagnostics
Industrial Chain Perspective
▸ Development and Application of Molecular Tumor Diagnostics and Personalized Therapy
▸ Frontier Trends in Liquid Biopsy: Personalized Panels Facilitate Stratified Diagnosis and Treatment of MRD, Enhancing Quality of Life for Cancer Patients
▸ Policy Differences Between LDTs and IVDs and Pathways for Conversion
▸ Advances in Genetic Testing Technology and Clinical Applications
▸ Innovations and Breakthroughs in Respiratory Detection
Ecological Perspective
▸ Roundtable Discussion: Opportunities and Challenges in Precision Diagnosis and Treatment
(More forums and agenda details will be updated gradually)
(Click to view larger image)
May 09 Medical Device Distributor Conference
May 09-10 Medical Device Design and Manufacturing Conference
May 09-10 Global Biomanufacturing Conference
May 10 Out-of-Hospital Market New Product & New Channel Growth Conference
Internet Hospital and Smart Hospital Forum, Pharmaceutical Company Digital Marketing Forum, Medical AI Large Model Application Innovation Forum, ITBT & AI Drug R&D Forum, Cardiovascular Disease Industry-Research Innovation Forum, Foreign Enterprise Digital Innovation Development Forum, Minimally Invasive Surgery Industry Innovation and Development Forum, CGT Venture Capital and BD New Opportunities Forum, Precision Medicine and Molecular Diagnostics Industry Development Forum, Health Management and Health Insurance Development Forum, Ophthalmology Industry Innovation and Development Forum...
More Forums to Be Updated
The 2025 Future Healthcare Top 100 List Release Ceremony and Innovation Awards Ceremony
Matchmaking sessions, closed-door meetings, project roadshows, high-end business events, etc.
★Themed Exhibition Area★
Innovative Medical Device Product Exhibition, Medical Device Design and Manufacturing Exhibition, Digital Health and Services Exhibition,
Biomanufacturing Thematic Exhibition, Life Science Instrumentation Exhibition, Health Consumer Goods Collective Exhibition,
Regional Government Park Exhibition, International Exhibition Area... More themed exhibition areas to be updated
[Click to Register] 2025 Future Healthcare Top 100 Selection
Exhibition Name:2025 VBEF Future Healthcare & Pharma Top 100 Exhibition
Exhibition Time:May 9–10, 2025
Venue:China · Suzhou · International Expo Center
Exhibition Scale:16,000+ patient visits
(More partners are being confirmed; please stay tuned to VBEF for the latest updates.)
Organizer:VCBeat
Co-organized by:VCBeat New Medicine, ATLATL Dart Innovation Center, Enshe Capital, Guoke Hengtai, He Eye Hospital, Probe Capital
Forum Supporting Organizations:MathWorks, Pivotal bioVenture, Alibaba DAMO Academy, Anjieming, Aoruiji, Boson Quantum, Bohe Innovation Center, Deneng Medicine, Dongmai Medical, Enshe Capital, Fanzhuo Group, Fuxin Sci-Tech Innovation, GeRui, Guotai Junan, He Eye Specialist Hospital, Hengxu Capital, Hunan Medical Device Industrial Park, Huamei Haolian, Huimei Digital Technology, Health Road, Jieshi Medical, JD Health, Jinghan New Materials, Legend Star, Linsheng Polymer, Lulutong Health, Lide Health, Mijian, Natray, Ping An Good Doctor, Puchuang Medical, Ruisen Medical, Shangyong Technology, Taozi Health, Tonghe Litai, Tupai Medical, Weimei Health, Xiyi Medicine, Xikang Cloud Hospital, Xinhong Electronics, Yanyin Technology, Yishu Health, Yijiada Medical, Zhejiang Kayee, Knowledge Matrix, Jones Lang LaSalle
Supported Parks:Changping Life Valley Industrial Base, Optics Valley Bio-City/Wuhan Gaoke Medical Device Park, Haicheng Digital Healthcare Industrial Park, Jiangsu Medical Device Technology Industrial Park, Shanghai Free Trade Zone No.1 Life Science and Technology Industrial Park, Zhongguancun (Tongzhou) Innovative Medical Translation Industrial Park (Yifang Health Valley)
Media Partners:21st Century Business Herald, E-Pharma Academy, MedWorld Device World, Bioon Valley, Touch Biology, Cyzone, Big Health School, Haodeya, Huihui Yaoka, Jixiao 361, Jiankangjie, Quick Doctor Inquiry, Bioon Valley, Taidu TIMEDOO, Tansi Biology, Investment Circle, Xiao Fan Zhuo, Xinxi Xia, Yao Fangzhou, Yaokahui, YAOZH, Medical Engineering Scholars, Yi Qianyan, DXY, Pharmaceutical Manager, PharmaCube, Zhiyi Xun
